GAMBRO GETS EUROPEAN APPROVAL OF NEW DIALYSIS SOLUTION.Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), Stockholm, Sweden, a leading international medical technology and healthcare company, has received European approval of a new solution product for peritoneal dialysis peritoneal dialysis n. The removal of soluble substances and water from the body by transfer across the peritoneum, utilizing a solution which is intermittently introduced into and removed from the peritoneal cavity. . It is a new unique "three-in-one" product concept which has been approved by the EEC EEC: see European Economic Community. Health Authorities through the mutual recognition procedure. The new product is part of Gambro's expansion strategy in the peritoneal peritoneal /peri·to·ne·al/ (per?i-to-ne´al) pertaining to the peritoneum. peritoneal pertaining to the peritoneum. sector based on innovative systems and products for this market which has a total global market value of about USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 1.7 billion. The new product concept derives from Gambro's leading research on glucose degradation. The product is called "Gambrosol(R) trio(R)" and is a polymer bag with a highly advanced design and which is handling the delicately composed solutions needed for peritoneal dialysis treatment. The bag is divided into three compartments. One compartment contains a mixture of lactate Lactate A salt or ester of lactic acid (CH3CHOHCOOH). In lactates, the acidic hydrogen of the carboxyl group has been replaced by a metal or an organic radical. Lactates are optically active, with a chiral center at carbon 2. , sodium, calcium, chloride and magnesium. The two other compartments contain concentrated glucose and sodium chloride sodium chloride, NaCl, common salt. Properties Sodium chloride is readily soluble in water and insoluble or only slightly soluble in most other liquids. It forms small, transparent, colorless to white cubic crystals. solutions. By breaking one or two frangible fran·gi·ble adj. Capable of being broken; breakable. See Synonyms at fragile. [Middle English, from Old French, from Medieval Latin frangibilis, from Latin frangere, to break pins at the time of use, the patient will get access to the specific glucose concentration needed. Previously patients or hospitals had to store and use two or three different types of bags with different glucose concentrations. Peritoneal dialysis can be performed at home, at work, when traveling or at a hospital or a clinic and involves substantial quantities of disposables including dialysis solutions. The new product tremendously simplifies the logistics of peritoneal products for home patients, clinics, hospitals as well as for Gambro. The sales of the Gambrosol(R) trio(R) product in European markets will start during the second quarter this year. Gambro Renal Products Gambro has a global leading position in products and systems for renal care including hemodialysis hemodialysis /he·mo·di·al·y·sis/ (-di-al´i-sis) removal of certain elements from the blood by virtue of the difference in rates of their diffusion through a semipermeable membrane while being circulated outside the body; the process , peritoneal dialysis and renal intensive care. Gambro Renal Products has annual sales of about USD 900 M and has about 6,000 employees. Products are marketed under the Gambro and Hospal brands and mainly include filters, machines, concentrates and bloodlines for dialysis. Products and services are sold in more than 90 countries including own sales organizations in 29 countries. Development of products and production technology is focused into product centers of excellence in Germany, Italy and Sweden. The global manufacturing organization includes sites in France, Germany, Italy, Sweden, Mexico, USA, Japan, China, South Korea and Australia. Research is performed by groups covering the main areas biology, medicine, treatment systems, membranes and devices. Research groups are located in Germany, France and Sweden. For more information, call 212/419 4258. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion